RECOMBINANT FHBP LIPOPROTEIN FROM NEISSERIA MENINGITIDIS SEROGROUP B RL2086 SUBFAMILY A
SpainMedications containing this active substance
-
Trumenba injectable suspension in pre-filled syringe
Form: suspension for injection
Active substance Dosage RECOMBINANT FHBP LIPOPROTEIN FROM NEISSERIA MENINGITIDIS SEROGROUP B RL2086 SUBFAMILY A 120 µg RECOMBINANT FHBP LIPOPROTEIN FROM NEISSERIA MENINGITIDIS SEROGROUP B RL2086 SUBFAMILY B 120 µg Manufacturer: Pfizer Europe Ma Eeig